Orgalutran Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Synthetic decapeptide ganirelix

Indications/Uses

Prevention of premature LH surges in women undergoing controlled ovarian hyperstimulation (COH) for assisted reproduction techniques.

Dosage/Direction for Use

SC 0.25 mg once daily starting on day 6 of FSH administration. COH w/ FSH may start at day 2 or 3 of menses. High responder Starting Orgalutran treatment on day 5 may prevent early LH rise.

Contraindications

Hypersensitivity to synthetic decapeptide ganirelix, gonadotrophin-releasing hormone (GnRH) or any other GnRH analogue. Moderate or severe renal or hepatic impairment. Pregnancy & lactation.

MIMS Class

Trophic Hormones & Related Synthetic Drugs

ATC Classification

H01CC01 - ganirelix ; Belongs to the class of anti-gonadotropin-releasing hormones. Used in hypothalamic hormone preparations.

Regulatory Classification

POM

Presentation/Packing

Form

Orgalutran soln for inj 0.25 mg/0.5 mL

Packing/Price

1's

Orgalutran

ganirelix

Manufacturer:

Vetter Pharma